Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Radiation Therapy × Axitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 11 Kidney Neoplasms 3 Neoplasms 2 Skin Neoplasms 1 Radiation Therapy 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Advanced Non-small Cell Lung Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06889649 2025-03-21

SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC

Peking University First Hospital

Phase 2 Recruiting

Radiation Therapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡